摘要 |
<p>The present invention relates to molecules which are immunointeractive with an animal growth factor receptor and, more particularly, to animal neuroepithelial kinase/fetal liver kinase-1 receptor (NYK/flk-1). The immunointeractive molecules provide the basis for new therapeutic and diagnostic agents useful in the treatment, prophylaxis and diagnosis of angiogenic-dependent phenotype.</p> |